Aardvark Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $9.7M |
| FY2024 | $5.4M | $77.5M | $61.6M |
| FY2025 | $10.5M | $117.2M | $47.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $9.7M |
| FY2024 | $5.4M | $77.5M | $61.6M |
| FY2025 | $10.5M | $117.2M | $47.1M |